SEC Filing Details

« back

SEC Filing Details

Document Details

Form
Filing Date
February 22, 2021
Document Date
February 22, 2021
Form Description
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filing Group
Registration Statements
Company
Nurix Therapeutics, Inc.
Issuer
NURIX THERAPEUTICS, INC.